Sandra Ann Springer, MD

Associate Professor of Medicine (AIDS) and Associate Clinical Professor of Nursing; Director, Infectious Disease Outpatient Clinic, Veterans Administration Healthcare Services, Newington

Departments & Organizations

Center for Interdisciplinary Research on AIDS

Internal Medicine: Infectious Diseases

Office of Student Research

Yale Medical Group


Sandra Springer, MD is an Associate Professor of Medicine in the Department of Internal Medicine, section of Infectious Diseases at the Yale School of Medicine. She is Board-Certified in Internal Medicine, Infectious Diseases and Addiction Medicine. Dr. Springer has significant research experience with adherence interventions for HIV-infected drug and alcohol dependent persons. She was a recipient of a NIDA-funded K23 mentored career development award, during which she evaluated the use of medication assisted treatment (MAT) to prevent relapse to opioid use as a conduit to care among HIV-infected opioid dependent released prisoners. She developed the first protocol to use buprenorphine as relapse prevention for opioid dependent HIV+ prisoners on day of release and has published these findings that serve as proof of concept that MAT can be effective in maintaining HIV+ released prisoners HIV clinical outcomes. She also has expertise in supervising RCTs by serving as medical director and co-investigator for multiple RCTs including DAART adherence interventions for IDUs and HIV+ released prisoners. She also has considerable clinical and research experience with the use of extended-release naltrexone and has been awarded an R01 from NIAAA as Principal Investigator to evaluate its use to prevent relapse to alcohol use among HIV infected alcohol dependent prisoners transitioning to the community and from NIDA as PI as part of the Seek Test Treat and Retain initiative to evaluate its use to prevent relapse to opioid use among opioid dependent released criminal justice populations as a means to maintain HIV treatment outcomes. She is also a co-investigator on an R01 from NIDA with Dr. Altice evaluating the use of buprenorphine as linkage to HIV testing and conduit to care for opioid dependent persons in Washington D.C and a co-investigator for a NIDA R01 with Dr. Altice (PI) that is implementing extended-release naltrexone for opioid dependent persons in Ukraine. She has a K02 independent scientist award from NIDA as well. Dr. Springer has expertise in the development and implementation of medication-assisted-therapy interventions involving HIV+, drug and alcohol dependent persons involved in the criminal justice setting.

Education & Training

MD University of Massachusetts (1998)
BA Harvard University (1990)
Fellow Yale School of Medicine
Resident Yale School of Medicine
Board Certification AB of Internal Medicine, Infectious Disease (2005)
Board Certification AB of Internal Medicine, Internal Medicine (2001)

Honors & Recognition

  • Invited Chair and Discussion of "Integrative Research on Injectable Extended-Release Naltrexone" Research Society on Alcoholism (2012)

  • Independent Scientist K-02 AwardNational Institute of Drug Abuse (2011)

  • Invited Reviewer of R01 Grants National Institute of Drug Abuse (NIDA) (2011)

  • Award for Outstanding Provider in the CommunityVNA- South Central Partnership (2007)

  • Recipient of the 2006 B. Jaye Anno Award of Excellence in Communication (2006)

  • Mentored Career Development K-23 AwardNational Institute of Drug Abuse (2005)

  • Bristol-Myers Squibb HIV Virology Fellowship AwardBristo-Myers Squibb (2002)

  • Academic Excellence Award for Women in Field of Medicine University of Massachusetts Medical School (1998)

International Activity

  • HIV/AIDS and Addiction Kiev, Ukraine (2012 - 2017)

    Technical Assistance and Research, implementation protocol for extended-release naltrexone in Ukraine

Edit this profile

Contact Info

Sandra Ann Springer, MD
Patient Care Locations
VA Connecticut Healthcare
950 Campbell Avenue

West Haven, CT 06516
Yale-New Haven Hospital
20 York Street

New Haven, CT 06510
Office Location
Yale AIDS Program135 College Street, Ste Suite 323
New Haven, CT 06510
Mailing Address
135 College Street
Suite 323

New Haven, CT 06510

Curriculum Vitae